Interleukin-2: Developing Additional Cytokine Gene Therapies Using Fibroblasts or Dendritic Cells to Enhance Tumor Immunity.

Autor: Lotze, Michael T., Shurin, Michael, Esche, Clemens, Tahara, Hideaki, Storkus, Walter, Kirkwood, John M., Whiteside, Theresa L., Elder, Elaine M., Okada, Hideho, Robbins, Paul
Zdroj: Cancer Journal from Scientific American; Feb2000, Vol. 6 Issue 1, pS61, 6p, 1 Color Photograph, 1 Chart, 1 Graph
Abstrakt: Investigates the feasibility of immunotherapeutic approaches using dendritic cells and FLT3 ligand. Potential antitumor activity of dendritic cells and FLT3 ligand; Efficacy of strategies on patients with metastatic melanoma and other solid tumors; Role of approaches in improving the efficacy of interleukin-2-based immunotherapy.
Databáze: Supplemental Index